0 items
September 12, 2022 — Boston Scientific Corporation has received U.S. Food and Drug Administration (FDA) approval to expand the instructions for use labeling for the current-generation WATCHMAN FLX ...
Left Atrial Appendage (LAA) Occluders
This channel includes news and new technology innovations about Left Atrial Appendage (LAA) Occluders. These close off the LAA in patients with atrial fibrillation to prevent the formation of stroke-causing clots in atrial fibrillation (AFib or AF) patients. LAA occlusion is often indicated for patients who do not tolerate anticoagulation therpy or have bleeding risks associated with use of that therapy.
-
-
May 25, 2022 — ŌNŌCOR LLC, a leader in endovascular safety technology, today announced it has received 510(k) U.S. Food and Drug Administration (FDA) clearance for its ŌNŌ retrieval system, the first ...
-
April 12, 2022 – Patients who had leakage to the left atrial appendage due to incomplete device sealing after left atrial appendage occlusion (LAAO) experienced more clotting and bleeding events ...
-
Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC DeviceFebruary 28, 2022 – Boston Scientific Corporation has announced positive results from a new analysis assessing real-world outcomes with the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device ...
September 12, 2022 — Boston Scientific Corporation has received U.S. Food and Drug Administration (FDA) approval to ...
September 12, 2022
June 27, 2022 — Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias ...
June 28, 2022
May 25, 2022 — ŌNŌCOR LLC, a leader in endovascular safety technology, today announced it has received 510(k) U.S. Food ...
May 25, 2022
April 12, 2022 – Patients who had leakage to the left atrial appendage due to incomplete device sealing after left ...
April 12, 2022
Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device
February 28, 2022 – Boston Scientific Corporation has announced positive results from a new analysis assessing real ...
February 28, 2022
The latest cardiology practice-changing scientific breakthrough, late-breaking study presentations have been announced ...
February 10, 2022
Christine Albert, M.D., MPH, professor, chair of the Department of Cardiology and the Lee and Harold Kapelovitz ...
November 22, 2021
November 8, 2021 – SWISS-APERO is the first randomized clinical trial comparing the Abbott Amulet left atrial appendage ...
November 08, 2021
Feature | By Dave Fornell, DAIC Editor
November 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...
November 01, 2021
October 6, 2021 — Boston Scientific Corp. announced it entered into a definitive agreement to acquire Baylis Medical ...
October 06, 2021
Feature | BY Dave Fornell, DAIC Editor
October 6, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...
October 06, 2021
September 27, 2021 — Compared with men undergoing left atrial appendage occlusion (LAAO), women have a significantly ...
September 27, 2021
August 31, 2021 — Late-breaking data from a head-to-head clinical trial of the Amulet Left Atrial Appendage (LAA) ...
August 31, 2021
August 16, 2021 — The U.S. Food and Drug Administration (FDA) approved Abbott's Amplatzer Amulet Left Atrial Appendage ...
August 16, 2021
July 13, 2021 — East End Medical announced it received U.S. Food and Drug Administration (FDA) clearance for the company ...
July 14, 2021© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now